Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pheochromocytoma, Metastatic”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Testing effectiveness (Phase 2)Study completedNCT03034200
What this trial is testing

Phase 2 Study of ONC201 in Neuroendocrine Tumors

Who this might be right for
Recurrent Neuroendocrine TumorMetastatic Neuroendocrine Tumor
Peter Anderson 30
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Not applicableEnded earlyNCT03986593
What this trial is testing

Cryoablation of Bone Metastases From Endocrine Tumors

Who this might be right for
Neoplasm MetastasisThyroid NeoplasmPheochromocytoma+3 more
Instituto do Cancer do Estado de São Paulo 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04394858
What this trial is testing

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

Who this might be right for
Advanced Adrenal Gland PheochromocytomaAdvanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+5 more
National Cancer Institute (NCI) 46
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01413503
What this trial is testing

A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors

Who this might be right for
PheochromocytomaParaganglioma
University of California, San Francisco 50
Early research (Phase 1)Study completedNCT00339131
What this trial is testing

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Who this might be right for
PheochromocytomaParagangliomaCarcinoid
Molecular Insight Pharmaceuticals, Inc. 24
Not applicableAvailableNCT03015844
What this trial is testing

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Who this might be right for
NeuroblastomaPheochromocytoma
Northwell Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT03946527
What this trial is testing

LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

Who this might be right for
ParagangliomaPheochromocytoma
Antonio Fojo 10
Testing effectiveness (Phase 2)Ended earlyNCT01340794
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Who this might be right for
Extra-Adrenal ParagangliomaMetastatic Adrenal Gland PheochromocytomaParaganglioma+1 more
National Cancer Institute (NCI) 7
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Looking for participantsNCT06427798
What this trial is testing

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Who this might be right for
Somatostatin Receptor PositiveGastrointestinal Neuroendocrine TumorsPheochromocytoma+1 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT01635907
What this trial is testing

Dovitinib in Neuroendocrine Tumors

Who this might be right for
Advanced Metastatic ParagangliomaAdvanced Metastatic PheochromocytomaRecurrent Paraganglioma+3 more
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Looking for participantsNCT07680205
What this trial is testing

An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

Who this might be right for
Pheochromocytoma and Paraganglioma (PPGL)Pheochromocytoma MalignantPheochromocytoma, Metastatic+2 more
Cambridge University Hospitals NHS Foundation Trust 12
Not applicableNo Longer AvailableNCT03649438
What this trial is testing

131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaMetastatic Pheochromocytoma
University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableNot Yet RecruitingNCT04788927
What this trial is testing

Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

Who this might be right for
ParagangliomaPheochromocytomaGenetic Predisposition to Disease+4 more
Rigshospitalet, Denmark 400
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Next Page